Analysts Offer Predictions for Cabot Corp’s Q2 2018 Earnings (CBT)

Cabot Corp (NYSE:CBT) – Equities researchers at SunTrust Banks upped their Q2 2018 earnings estimates for Cabot in a research report issued on Tuesday. SunTrust Banks analyst J. Sheehan now expects that the specialty chemicals company will post earnings per share of $1.00 for the quarter, up from their prior estimate of $0.98. SunTrust Banks currently has a “Buy” rating on the stock. SunTrust Banks also issued estimates for Cabot’s Q3 2018 earnings at $1.06 EPS, Q4 2018 earnings at $1.08 EPS, FY2018 earnings at $3.87 EPS and FY2019 earnings at $4.27 EPS.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.93 by ($0.02). The business had revenue of $723.00 million for the quarter, compared to analysts’ expectations of $683.30 million. Cabot had a return on equity of 15.11% and a net margin of 8.87%. The company’s revenue was up 16.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.00 EPS.

Several other research analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Cabot from a “buy” rating to a “hold” rating in a research note on Tuesday, November 7th. Jefferies Group reiterated a “buy” rating and set a $74.00 price target on shares of Cabot in a research note on Friday, November 3rd. KeyCorp reiterated a “hold” rating on shares of Cabot in a research note on Wednesday, November 1st. Finally, Loop Capital began coverage on shares of Cabot in a research note on Thursday, September 28th. They set a “hold” rating and a $59.00 target price on the stock. Six analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $61.14.

Shares of Cabot (NYSE:CBT) traded up $2.91 during trading on Wednesday, hitting $61.27. 699,700 shares of the stock traded hands, compared to its average volume of 339,282. The stock has a market cap of $3,615.38, a PE ratio of 17.01, a PEG ratio of 1.55 and a beta of 1.11. Cabot has a 1-year low of $50.21 and a 1-year high of $64.66. The company has a quick ratio of 1.17, a current ratio of 1.70 and a debt-to-equity ratio of 0.41.

The company also recently announced a quarterly dividend, which was paid on Friday, December 8th. Investors of record on Friday, November 24th were paid a dividend of $0.315 per share. This represents a $1.26 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date of this dividend was Wednesday, November 22nd. Cabot’s dividend payout ratio (DPR) is 33.07%.

Several institutional investors and hedge funds have recently added to or reduced their stakes in CBT. AJO LP lifted its stake in shares of Cabot by 196.4% during the 2nd quarter. AJO LP now owns 918,731 shares of the specialty chemicals company’s stock valued at $49,088,000 after buying an additional 608,799 shares in the last quarter. BlackRock Inc. lifted its stake in shares of Cabot by 7.2% during the 2nd quarter. BlackRock Inc. now owns 7,544,005 shares of the specialty chemicals company’s stock valued at $403,077,000 after buying an additional 505,594 shares in the last quarter. Earnest Partners LLC lifted its stake in shares of Cabot by 41.8% during the 2nd quarter. Earnest Partners LLC now owns 1,491,521 shares of the specialty chemicals company’s stock valued at $79,692,000 after buying an additional 439,350 shares in the last quarter. BNP Paribas Arbitrage SA lifted its stake in shares of Cabot by 433.2% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 440,191 shares of the specialty chemicals company’s stock valued at $24,563,000 after buying an additional 357,639 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Cabot by 37.9% during the 3rd quarter. Victory Capital Management Inc. now owns 1,102,342 shares of the specialty chemicals company’s stock valued at $61,511,000 after buying an additional 302,750 shares in the last quarter. Institutional investors own 84.83% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Analysts Offer Predictions for Cabot Corp’s Q2 2018 Earnings (CBT)” was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://sportsperspectives.com/2017/12/20/analysts-offer-predictions-for-cabot-corps-q2-2018-earnings-cbt.html.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply